-
By Tom Murphy |
March 19, 2013
Drugstore chain Walgreen's fiscal second-quarter earnings climbed 11 percent, helped by contributions from European health and beauty retailer Alliance Boots, a business sale gain, and its new contract with Express Scripts Holding Co.
-
By The Associated Press |
September 20, 2012
Arizona is suing the nation's largest drug wholesaler, claiming the company violated state consumer protection laws by artificially inflating the prices of hundreds of brand-name prescription drugs.
-
By Andy Stonehouse |
August 29, 2012
The earth-shattering truth? The fees on my 401(k) add up to the same price as a Sausage McMuffin.
-
By Paula Aven Gladych |
July 16, 2012
Industries tackling the obesity epidemic are slowly becoming an investment opportunity.
-
By Linda A. Johnson, AP Business Writer |
June 28, 2012
The Supreme Court's decision Thursday to uphold President Barack Obama's historic overhaul is expected to be a boon to most of the health care industry by making coverage more affordable for millions of uninsured Americans.
-
By Mark Jewell |
May 18, 2012
Investors who see opportunity in Asia's growth typically think of China first. That's one reason why there's no shortage of options for U.S. investors looking to buy a stock mutual fund that focuses on China.
-
By Kevin Host |
April 1, 2012
To say there’s a growing demand for specialty pharmacy is an understatement of vast proportions.
-
By Kathryn Mayer |
March 19, 2012
Take a look at what are the best-selling specialty drugs.
-
By Kevin Host |
March 19, 2012
To say there's a growing demand for specialty pharmacy is an understatement of vast proportions.
-
By Michael Virtanen |
February 14, 2012
With New York medical practitioners issuing more painkiller prescriptions in one year than the state has residents, the Senate passed legislation Monday meant to curb the illegal trade and illicit use of hydrocodone and other addictive opioid drugs.